Cargando…
Effects and Safety of an Oral Adsorbent on Chronic Kidney Disease Progression: A Systematic Review and Meta-Analysis
Background: AST-120 (Kremezin), which is an oral spherical carbon adsorbent, has been reported to have the potential for retarding disease progression in patients with chronic kidney disease. We aimed to evaluate its efficacy and safety in this study. Methods: We systematically searched for randomiz...
Autores principales: | Chen, Ying-Chun, Wu, Mei-Yi, Hu, Ping-Jen, Chen, Tzu-Ting, Shen, Wan-Chen, Chang, Wei-Chiao, Wu, Mai-Szu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832608/ https://www.ncbi.nlm.nih.gov/pubmed/31627462 http://dx.doi.org/10.3390/jcm8101718 |
Ejemplares similares
-
Efficacy of Osteoporosis Medications for Patients With Chronic Kidney Disease: An Updated Systematic Review and Network Meta-Analysis
por: Chen, Chia-Hsien, et al.
Publicado: (2022) -
A National Case-Crossover Study on the Risk of Kidney Injury Requiring Dialysis after Sepsis
por: Wong, Chung-Shun, et al.
Publicado: (2023) -
Association of UBE3C Variants with Reduced Kidney Function in Patients with Diabetic Kidney Disease
por: Chen, Ying-Chun, et al.
Publicado: (2020) -
Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis
por: Wu, Mei-Yi, et al.
Publicado: (2017) -
Correction: Effects and safety of oral tolvaptan in patients with congestive heart failure: A systematic review and network meta-analysis
por: Wu, Mei-Yi, et al.
Publicado: (2019)